Targeting the Tumor Stroma in Cancer Therapy

被引:29
|
作者
Anton, Kevin [2 ]
Glod, John [1 ,2 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pediat Oncol, New Brunswick, NJ 08903 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pharmacol, New Brunswick, NJ 08903 USA
关键词
MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; METALLOPROTEINASE INHIBITOR PRINOMASTAT; PLASMINOGEN-ACTIVATOR SYSTEM; TYROSINE KINASE INHIBITOR; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; PHASE-II; MACROPHAGE INFILTRATION; PROTEIN-ALPHA;
D O I
10.2174/138920109787315088
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increasing evidence shows that the interaction between neoplastic cells and the surrounding stroma is a critical factor in solid tumor growth. The tumor stroma is made up of diverse cellular populations including macrophages, lymphocytes, vascular cells, and carcinoma-associated fibroblasts. The complex interactions between the stroma and neoplastic cells are largely unexplored. Initial therapies aimed at disrupting angiogenesis within the tumor microenvironment have met with success in a number of tumor types. An improved understanding of stromal signaling pathways is likely to identify additional novel therapeutic targets.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 50 条
  • [21] Targeting the Tumor Microenvironment for Cancer Therapy
    Sounni, Nor Eddine
    Noel, Agnes
    CLINICAL CHEMISTRY, 2013, 59 (01) : 85 - 93
  • [22] Targeting tumor microenvironment in cancer therapy
    Singh, Shree Ram
    Rameshwar, Pranela
    Siegel, Peter
    CANCER LETTERS, 2016, 380 (01) : 203 - 204
  • [23] Targeting Tumor Microenvironment for Cancer Therapy
    Roma-Rodrigues, Catarina
    Mendes, Rita
    Baptista, Pedro V.
    Fernandes, Alexandra R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (04)
  • [24] Tumor stroma in the development of acquired cancer therapy resistance.
    Gomez-Escudero, Jesus
    Maniati, Eleni
    Whiting, Freddie
    Wang, Jun
    Graham, Trevor
    Hodivala-Dilke, Kairbaan
    CANCER RESEARCH, 2020, 80 (11) : 48 - 48
  • [25] Mitigating tumor-stroma metabolic symbiosis for cancer therapy
    Kumar, Dhruv
    New, Jacob
    Vishwakarma, Vikalp
    Chavan, Hemant
    Kasturi, Partha
    Thomas, Sufi M.
    CANCER RESEARCH, 2017, 77
  • [26] Modulating Tumor Immunity by Targeting Tumor Fibrotic Stroma and Angiogenic Vessels for Lung Cancer Treatment
    Yuan, Yi
    Mishra, Falguni
    Li, Bin
    Peng, Guangda
    Chan, Payton
    Yang, Jenny
    Liu, Zhiren
    CANCERS, 2024, 16 (13)
  • [27] Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma
    Li, Yuanke
    Zhao, Zhen
    Liu, Hao
    Fetse, John Peter
    Jain, Akshay
    Lin, Chien-Yu
    Cheng, Kun
    ACS APPLIED MATERIALS & INTERFACES, 2019, 11 (49) : 45390 - 45403
  • [28] Transient targeting of the pancreatic cancer stroma as a 'fine-tuned' anti-tumor and anti-metastatic therapy
    Vennin, Claire
    Cox, Thomas R.
    Pajic, Marina
    Timpson, Paul
    ONCOTARGET, 2017, 8 (49) : 84635 - 84636
  • [29] Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
    Everts, Anne
    Bergeman, Melissa
    McFadden, Grant
    Kemp, Vera
    BIOMEDICINES, 2020, 8 (11) : 1 - 20
  • [30] Therapeutic targeting of tumor--stroma interactions
    Hiscox, Stephen
    Barrett-Lee, Peter
    Nicholson, Robert I.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (05) : 609 - 621